Global Interventional Oncology Ablation Device Supply, Demand and Key Producers, 2026-2032
The global Interventional Oncology Ablation Device market size is expected to reach $ 5594 million by 2032, rising at a market growth of 10.3% CAGR during the forecast period (2026-2032).
Interventional oncology ablation devices refer to integrated image-guided medical systems that deliver controlled physical energy—such as radiofrequency, microwave, cryoablation, laser, or high-intensity focused ultrasound—via percutaneous or endoluminal approaches to induce irreversible tumor necrosis. These systems typically consist of energy generators, ablation probes or electrodes, catheter-based delivery systems, and imaging navigation and control modules using CT, ultrasound, or MRI guidance, enabling precise targeting and real-time energy control. Widely applied in treating solid tumors such as liver, lung, kidney cancers, and bone metastases, they are often combined with vascular interventional techniques to form a comprehensive therapeutic framework. With advantages including minimal invasiveness, high safety, rapid recovery, and repeatability, these devices are evolving from single-modality tools into core platforms within integrated interventional oncology treatment systems.The average gross profit margin of this product is 72%.
With global shifts in cancer incidence patterns and the continuous improvement of early screening systems, oncology treatment is rapidly transitioning from surgery-dominant approaches to image-guided minimally invasive therapies, driving a systemic growth cycle for interventional oncology ablation devices. Corporate reports and investment analyses indicate continuous advancements in RF, microwave, and cryo energy platforms, combined with breakthroughs in imaging fusion and intelligent navigation, significantly improving precision and safety. Meanwhile, government-driven tiered healthcare and day-surgery initiatives are accelerating the penetration of advanced interventional systems into primary and specialty care settings, shifting the industry from standalone device procurement to integrated solution adoption.
Despite clear technological convergence, the industry still faces challenges such as complex multidisciplinary coordination and the lack of standardized clinical pathways. Treatment consistency across different ablation modalities in complex tumors remains variable, with high reliance on physician expertise and training systems. High costs of advanced equipment and consumables, along with delayed reimbursement and clinical guideline updates, constrain market expansion in certain regions. Additionally, established surgical and radiotherapy systems continue to exert competitive substitution pressure.
Clinical practice is shifting from single-modality treatment toward multidisciplinary interventional oncology systems. Applications of ablation devices continue to expand in liver cancer, lung nodules, and metastatic tumors. Increasing patient demand for minimal invasiveness, faster recovery, and improved quality of life is driving the growth of outpatient and day-care procedures. Furthermore, the trend toward chronic cancer management is reinforcing long-term follow-up and repeat treatment needs, transforming devices from one-time therapeutic tools into sustained treatment platforms with stable clinical demand structures.
Key upstream components include RF and microwave energy modules, cryogenic systems, medical-grade metals, catheter and guidewire systems, and polymer insulation materials, all critical to energy delivery stability and clinical safety. Industry disclosures indicate that while domestic precision manufacturing and electronics capabilities are improving, enabling partial localization of components, high-end imaging sensors and core fusion algorithms still rely on imports. The supply chain is evolving toward system integration and platform-based development, with upstream players transitioning from component suppliers to comprehensive solution providers, driving overall value chain upgrading.
This report studies the global Interventional Oncology Ablation Device demand, key companies, and key regions.
This report is a detailed and comprehensive analysis of the world market for Interventional Oncology Ablation Device, and provides market size (US$ million) and Year-over-Year (YoY) growth, considering 2025 as the base year. This report explores demand trends and competition, as well as details the characteristics of Interventional Oncology Ablation Device that contribute to its increasing demand across many markets.
Highlights and key features of the study
Global Interventional Oncology Ablation Device total market, 2021-2032, (USD Million)
Global Interventional Oncology Ablation Device total market by region & country, CAGR, 2021-2032, (USD Million)
U.S. VS China: Interventional Oncology Ablation Device total market, key domestic companies, and share, (USD Million)
Global Interventional Oncology Ablation Device revenue by player, revenue and market share 2021-2026, (USD Million)
Global Interventional Oncology Ablation Device total market by Energy Source, CAGR, 2021-2032, (USD Million)
Global Interventional Oncology Ablation Device total market by Procedure Type, CAGR, 2021-2032, (USD Million)
This report profiles major players in the global Interventional Oncology Ablation Device market based on the following parameters - company overview, revenue, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Chongqing Haifu Medical, AngioDynamics, Boston Scientific, Medtronic, Yigao Medical, Haijieya, Beijing Weierfu, Micro Tech Medical, Better Medical, Vison Medical, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the world Interventional Oncology Ablation Device market
Detailed Segmentation:
Each section contains quantitative market data including market by value (US$ Millions), by player, by regions, by Energy Source, and by Procedure Type. Data is given for the years 2021-2032 by year with 2025 as the base year, 2026 as the estimate year, and 2027-2032 as the forecast year.
Global Interventional Oncology Ablation Device Market, By Region:
1. How big is the global Interventional Oncology Ablation Device market?
2. What is the demand of the global Interventional Oncology Ablation Device market?
3. What is the year over year growth of the global Interventional Oncology Ablation Device market?
4. What is the total value of the global Interventional Oncology Ablation Device market?
5. Who are the Major Players in the global Interventional Oncology Ablation Device market?
6. What are the growth factors driving the market demand?
Interventional oncology ablation devices refer to integrated image-guided medical systems that deliver controlled physical energy—such as radiofrequency, microwave, cryoablation, laser, or high-intensity focused ultrasound—via percutaneous or endoluminal approaches to induce irreversible tumor necrosis. These systems typically consist of energy generators, ablation probes or electrodes, catheter-based delivery systems, and imaging navigation and control modules using CT, ultrasound, or MRI guidance, enabling precise targeting and real-time energy control. Widely applied in treating solid tumors such as liver, lung, kidney cancers, and bone metastases, they are often combined with vascular interventional techniques to form a comprehensive therapeutic framework. With advantages including minimal invasiveness, high safety, rapid recovery, and repeatability, these devices are evolving from single-modality tools into core platforms within integrated interventional oncology treatment systems.The average gross profit margin of this product is 72%.
With global shifts in cancer incidence patterns and the continuous improvement of early screening systems, oncology treatment is rapidly transitioning from surgery-dominant approaches to image-guided minimally invasive therapies, driving a systemic growth cycle for interventional oncology ablation devices. Corporate reports and investment analyses indicate continuous advancements in RF, microwave, and cryo energy platforms, combined with breakthroughs in imaging fusion and intelligent navigation, significantly improving precision and safety. Meanwhile, government-driven tiered healthcare and day-surgery initiatives are accelerating the penetration of advanced interventional systems into primary and specialty care settings, shifting the industry from standalone device procurement to integrated solution adoption.
Despite clear technological convergence, the industry still faces challenges such as complex multidisciplinary coordination and the lack of standardized clinical pathways. Treatment consistency across different ablation modalities in complex tumors remains variable, with high reliance on physician expertise and training systems. High costs of advanced equipment and consumables, along with delayed reimbursement and clinical guideline updates, constrain market expansion in certain regions. Additionally, established surgical and radiotherapy systems continue to exert competitive substitution pressure.
Clinical practice is shifting from single-modality treatment toward multidisciplinary interventional oncology systems. Applications of ablation devices continue to expand in liver cancer, lung nodules, and metastatic tumors. Increasing patient demand for minimal invasiveness, faster recovery, and improved quality of life is driving the growth of outpatient and day-care procedures. Furthermore, the trend toward chronic cancer management is reinforcing long-term follow-up and repeat treatment needs, transforming devices from one-time therapeutic tools into sustained treatment platforms with stable clinical demand structures.
Key upstream components include RF and microwave energy modules, cryogenic systems, medical-grade metals, catheter and guidewire systems, and polymer insulation materials, all critical to energy delivery stability and clinical safety. Industry disclosures indicate that while domestic precision manufacturing and electronics capabilities are improving, enabling partial localization of components, high-end imaging sensors and core fusion algorithms still rely on imports. The supply chain is evolving toward system integration and platform-based development, with upstream players transitioning from component suppliers to comprehensive solution providers, driving overall value chain upgrading.
This report studies the global Interventional Oncology Ablation Device demand, key companies, and key regions.
This report is a detailed and comprehensive analysis of the world market for Interventional Oncology Ablation Device, and provides market size (US$ million) and Year-over-Year (YoY) growth, considering 2025 as the base year. This report explores demand trends and competition, as well as details the characteristics of Interventional Oncology Ablation Device that contribute to its increasing demand across many markets.
Highlights and key features of the study
Global Interventional Oncology Ablation Device total market, 2021-2032, (USD Million)
Global Interventional Oncology Ablation Device total market by region & country, CAGR, 2021-2032, (USD Million)
U.S. VS China: Interventional Oncology Ablation Device total market, key domestic companies, and share, (USD Million)
Global Interventional Oncology Ablation Device revenue by player, revenue and market share 2021-2026, (USD Million)
Global Interventional Oncology Ablation Device total market by Energy Source, CAGR, 2021-2032, (USD Million)
Global Interventional Oncology Ablation Device total market by Procedure Type, CAGR, 2021-2032, (USD Million)
This report profiles major players in the global Interventional Oncology Ablation Device market based on the following parameters - company overview, revenue, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Chongqing Haifu Medical, AngioDynamics, Boston Scientific, Medtronic, Yigao Medical, Haijieya, Beijing Weierfu, Micro Tech Medical, Better Medical, Vison Medical, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the world Interventional Oncology Ablation Device market
Detailed Segmentation:
Each section contains quantitative market data including market by value (US$ Millions), by player, by regions, by Energy Source, and by Procedure Type. Data is given for the years 2021-2032 by year with 2025 as the base year, 2026 as the estimate year, and 2027-2032 as the forecast year.
Global Interventional Oncology Ablation Device Market, By Region:
- United States
- China
- Europe
- Japan
- South Korea
- ASEAN
- India
- Rest of World
- Microwave Ablation
- Radiofrequency Ablation
- Cryoablation
- High-Intensity Focused Ultrasound (HIFU)
- Others
- Liver Cancer
- Lung Cancer
- Breast Cancer
- Other
- Chongqing Haifu Medical
- AngioDynamics
- Boston Scientific
- Medtronic
- Yigao Medical
- Haijieya
- Beijing Weierfu
- Micro Tech Medical
- Better Medical
- Vison Medical
- Shanghai Maide
- HealthTronics
- J &J
- EDAP TMS
- Sonacare Medical
- Misonix
1. How big is the global Interventional Oncology Ablation Device market?
2. What is the demand of the global Interventional Oncology Ablation Device market?
3. What is the year over year growth of the global Interventional Oncology Ablation Device market?
4. What is the total value of the global Interventional Oncology Ablation Device market?
5. Who are the Major Players in the global Interventional Oncology Ablation Device market?
6. What are the growth factors driving the market demand?
1 SUPPLY SUMMARY
1.1 Interventional Oncology Ablation Device Introduction
1.2 World Interventional Oncology Ablation Device Market Size & Forecast (2021 & 2025 & 2032)
1.3 World Interventional Oncology Ablation Device Total Market by Region (by Headquarter Location)
1.3.1 World Interventional Oncology Ablation Device Market Size by Region (2021-2032), (by Headquarter Location)
1.3.2 United States Based Company Interventional Oncology Ablation Device Revenue (2021-2032)
1.3.3 China Based Company Interventional Oncology Ablation Device Revenue (2021-2032)
1.3.4 Europe Based Company Interventional Oncology Ablation Device Revenue (2021-2032)
1.3.5 Japan Based Company Interventional Oncology Ablation Device Revenue (2021-2032)
1.3.6 South Korea Based Company Interventional Oncology Ablation Device Revenue (2021-2032)
1.3.7 ASEAN Based Company Interventional Oncology Ablation Device Revenue (2021-2032)
1.3.8 India Based Company Interventional Oncology Ablation Device Revenue (2021-2032)
1.4 Market Drivers, Restraints and Trends
1.4.1 Interventional Oncology Ablation Device Market Drivers
1.4.2 Factors Affecting Demand
1.4.3 Major Market Trends
2 DEMAND SUMMARY
2.1 World Interventional Oncology Ablation Device Consumption Value (2021-2032)
2.2 World Interventional Oncology Ablation Device Consumption Value by Region
2.2.1 World Interventional Oncology Ablation Device Consumption Value by Region (2021-2026)
2.2.2 World Interventional Oncology Ablation Device Consumption Value Forecast by Region (2027-2032)
2.3 United States Interventional Oncology Ablation Device Consumption Value (2021-2032)
2.4 China Interventional Oncology Ablation Device Consumption Value (2021-2032)
2.5 Europe Interventional Oncology Ablation Device Consumption Value (2021-2032)
2.6 Japan Interventional Oncology Ablation Device Consumption Value (2021-2032)
2.7 South Korea Interventional Oncology Ablation Device Consumption Value (2021-2032)
2.8 ASEAN Interventional Oncology Ablation Device Consumption Value (2021-2032)
2.9 India Interventional Oncology Ablation Device Consumption Value (2021-2032)
3 WORLD INTERVENTIONAL ONCOLOGY ABLATION DEVICE COMPANIES COMPETITIVE ANALYSIS
3.1 World Interventional Oncology Ablation Device Revenue by Player (2021-2026)
3.2 Industry Rank and Concentration Rate (CR)
3.2.1 Global Interventional Oncology Ablation Device Industry Rank of Major Players
3.2.2 Global Concentration Ratios (CR4) for Interventional Oncology Ablation Device in 2025
3.2.3 Global Concentration Ratios (CR8) for Interventional Oncology Ablation Device in 2025
3.3 Interventional Oncology Ablation Device Company Evaluation Quadrant
3.4 Interventional Oncology Ablation Device Market: Overall Company Footprint Analysis
3.4.1 Interventional Oncology Ablation Device Market: Region Footprint
3.4.2 Interventional Oncology Ablation Device Market: Company Product Type Footprint
3.4.3 Interventional Oncology Ablation Device Market: Company Product Application Footprint
3.5 Competitive Environment
3.5.1 Historical Structure of the Industry
3.5.2 Barriers of Market Entry
3.5.3 Factors of Competition
3.6 Mergers & Acquisitions Activity
4 UNITED STATES VS CHINA VS REST OF WORLD (BY HEADQUARTER LOCATION)
4.1 United States VS China: Interventional Oncology Ablation Device Revenue Comparison (by Headquarter Location)
4.1.1 United States VS China: Interventional Oncology Ablation Device Revenue Comparison (2021 & 2025 & 2032) (by Headquarter Location)
4.1.2 United States VS China: Interventional Oncology Ablation Device Revenue Market Share Comparison (2021 & 2025 & 2032)
4.2 United States Based Companies VS China Based Companies: Interventional Oncology Ablation Device Consumption Value Comparison
4.2.1 United States VS China: Interventional Oncology Ablation Device Consumption Value Comparison (2021 & 2025 & 2032)
4.2.2 United States VS China: Interventional Oncology Ablation Device Consumption Value Market Share Comparison (2021 & 2025 & 2032)
4.3 United States Based Interventional Oncology Ablation Device Companies and Market Share, 2021-2026
4.3.1 United States Based Interventional Oncology Ablation Device Companies, Headquarters (States, Country)
4.3.2 United States Based Companies Interventional Oncology Ablation Device Revenue, (2021-2026)
4.4 China Based Companies Interventional Oncology Ablation Device Revenue and Market Share, 2021-2026
4.4.1 China Based Interventional Oncology Ablation Device Companies, Company Headquarters (Province, Country)
4.4.2 China Based Companies Interventional Oncology Ablation Device Revenue, (2021-2026)
4.5 Rest of World Based Interventional Oncology Ablation Device Companies and Market Share, 2021-2026
4.5.1 Rest of World Based Interventional Oncology Ablation Device Companies, Headquarters (Province, Country)
4.5.2 Rest of World Based Companies Interventional Oncology Ablation Device Revenue (2021-2026)
5 MARKET ANALYSIS BY ENERGY SOURCE
5.1 World Interventional Oncology Ablation Device Market Size Overview by Energy Source: 2021 VS 2025 VS 2032
5.2 Segment Introduction by Energy Source
5.2.1 Microwave Ablation
5.2.2 Radiofrequency Ablation
5.2.3 Cryoablation
5.2.4 High-Intensity Focused Ultrasound (HIFU)
5.2.5 Others
5.3 Market Segment by Energy Source
5.3.1 World Interventional Oncology Ablation Device Market Size by Energy Source (2021-2026)
5.3.2 World Interventional Oncology Ablation Device Market Size by Energy Source (2027-2032)
5.3.3 World Interventional Oncology Ablation Device Market Size Market Share by Energy Source (2027-2032)
6 MARKET ANALYSIS BY PROCEDURE TYPE
6.1 World Interventional Oncology Ablation Device Market Size Overview by Procedure Type: 2021 VS 2025 VS 2032
6.2 Segment Introduction by Procedure Type
6.2.1 Liver Cancer
6.2.2 Lung Cancer
6.2.3 Breast Cancer
6.2.4 Other
6.3 Market Segment by Procedure Type
6.3.1 World Interventional Oncology Ablation Device Market Size by Procedure Type (2021-2026)
6.3.2 World Interventional Oncology Ablation Device Market Size by Procedure Type (2027-2032)
6.3.3 World Interventional Oncology Ablation Device Market Size Market Share by Procedure Type (2021-2032)
7 COMPANY PROFILES
7.1 Chongqing Haifu Medical
7.1.1 Chongqing Haifu Medical Details
7.1.2 Chongqing Haifu Medical Major Business
7.1.3 Chongqing Haifu Medical Interventional Oncology Ablation Device Product and Services
7.1.4 Chongqing Haifu Medical Interventional Oncology Ablation Device Revenue, Gross Margin and Market Share (2021-2026)
7.1.5 Chongqing Haifu Medical Recent Developments/Updates
7.1.6 Chongqing Haifu Medical Competitive Strengths & Weaknesses
7.2 AngioDynamics
7.2.1 AngioDynamics Details
7.2.2 AngioDynamics Major Business
7.2.3 AngioDynamics Interventional Oncology Ablation Device Product and Services
7.2.4 AngioDynamics Interventional Oncology Ablation Device Revenue, Gross Margin and Market Share (2021-2026)
7.2.5 AngioDynamics Recent Developments/Updates
7.2.6 AngioDynamics Competitive Strengths & Weaknesses
7.3 Boston Scientific
7.3.1 Boston Scientific Details
7.3.2 Boston Scientific Major Business
7.3.3 Boston Scientific Interventional Oncology Ablation Device Product and Services
7.3.4 Boston Scientific Interventional Oncology Ablation Device Revenue, Gross Margin and Market Share (2021-2026)
7.3.5 Boston Scientific Recent Developments/Updates
7.3.6 Boston Scientific Competitive Strengths & Weaknesses
7.4 Medtronic
7.4.1 Medtronic Details
7.4.2 Medtronic Major Business
7.4.3 Medtronic Interventional Oncology Ablation Device Product and Services
7.4.4 Medtronic Interventional Oncology Ablation Device Revenue, Gross Margin and Market Share (2021-2026)
7.4.5 Medtronic Recent Developments/Updates
7.4.6 Medtronic Competitive Strengths & Weaknesses
7.5 Yigao Medical
7.5.1 Yigao Medical Details
7.5.2 Yigao Medical Major Business
7.5.3 Yigao Medical Interventional Oncology Ablation Device Product and Services
7.5.4 Yigao Medical Interventional Oncology Ablation Device Revenue, Gross Margin and Market Share (2021-2026)
7.5.5 Yigao Medical Recent Developments/Updates
7.5.6 Yigao Medical Competitive Strengths & Weaknesses
7.6 Haijieya
7.6.1 Haijieya Details
7.6.2 Haijieya Major Business
7.6.3 Haijieya Interventional Oncology Ablation Device Product and Services
7.6.4 Haijieya Interventional Oncology Ablation Device Revenue, Gross Margin and Market Share (2021-2026)
7.6.5 Haijieya Recent Developments/Updates
7.6.6 Haijieya Competitive Strengths & Weaknesses
7.7 Beijing Weierfu
7.7.1 Beijing Weierfu Details
7.7.2 Beijing Weierfu Major Business
7.7.3 Beijing Weierfu Interventional Oncology Ablation Device Product and Services
7.7.4 Beijing Weierfu Interventional Oncology Ablation Device Revenue, Gross Margin and Market Share (2021-2026)
7.7.5 Beijing Weierfu Recent Developments/Updates
7.7.6 Beijing Weierfu Competitive Strengths & Weaknesses
7.8 Micro Tech Medical
7.8.1 Micro Tech Medical Details
7.8.2 Micro Tech Medical Major Business
7.8.3 Micro Tech Medical Interventional Oncology Ablation Device Product and Services
7.8.4 Micro Tech Medical Interventional Oncology Ablation Device Revenue, Gross Margin and Market Share (2021-2026)
7.8.5 Micro Tech Medical Recent Developments/Updates
7.8.6 Micro Tech Medical Competitive Strengths & Weaknesses
7.9 Better Medical
7.9.1 Better Medical Details
7.9.2 Better Medical Major Business
7.9.3 Better Medical Interventional Oncology Ablation Device Product and Services
7.9.4 Better Medical Interventional Oncology Ablation Device Revenue, Gross Margin and Market Share (2021-2026)
7.9.5 Better Medical Recent Developments/Updates
7.9.6 Better Medical Competitive Strengths & Weaknesses
7.10 Vison Medical
7.10.1 Vison Medical Details
7.10.2 Vison Medical Major Business
7.10.3 Vison Medical Interventional Oncology Ablation Device Product and Services
7.10.4 Vison Medical Interventional Oncology Ablation Device Revenue, Gross Margin and Market Share (2021-2026)
7.10.5 Vison Medical Recent Developments/Updates
7.10.6 Vison Medical Competitive Strengths & Weaknesses
7.11 Shanghai Maide
7.11.1 Shanghai Maide Details
7.11.2 Shanghai Maide Major Business
7.11.3 Shanghai Maide Interventional Oncology Ablation Device Product and Services
7.11.4 Shanghai Maide Interventional Oncology Ablation Device Revenue, Gross Margin and Market Share (2021-2026)
7.11.5 Shanghai Maide Recent Developments/Updates
7.11.6 Shanghai Maide Competitive Strengths & Weaknesses
7.12 HealthTronics
7.12.1 HealthTronics Details
7.12.2 HealthTronics Major Business
7.12.3 HealthTronics Interventional Oncology Ablation Device Product and Services
7.12.4 HealthTronics Interventional Oncology Ablation Device Revenue, Gross Margin and Market Share (2021-2026)
7.12.5 HealthTronics Recent Developments/Updates
7.12.6 HealthTronics Competitive Strengths & Weaknesses
7.13 J &J
7.13.1 J &J Details
7.13.2 J &J Major Business
7.13.3 J &J Interventional Oncology Ablation Device Product and Services
7.13.4 J &J Interventional Oncology Ablation Device Revenue, Gross Margin and Market Share (2021-2026)
7.13.5 J &J Recent Developments/Updates
7.13.6 J &J Competitive Strengths & Weaknesses
7.14 EDAP TMS
7.14.1 EDAP TMS Details
7.14.2 EDAP TMS Major Business
7.14.3 EDAP TMS Interventional Oncology Ablation Device Product and Services
7.14.4 EDAP TMS Interventional Oncology Ablation Device Revenue, Gross Margin and Market Share (2021-2026)
7.14.5 EDAP TMS Recent Developments/Updates
7.14.6 EDAP TMS Competitive Strengths & Weaknesses
7.15 Sonacare Medical
7.15.1 Sonacare Medical Details
7.15.2 Sonacare Medical Major Business
7.15.3 Sonacare Medical Interventional Oncology Ablation Device Product and Services
7.15.4 Sonacare Medical Interventional Oncology Ablation Device Revenue, Gross Margin and Market Share (2021-2026)
7.15.5 Sonacare Medical Recent Developments/Updates
7.15.6 Sonacare Medical Competitive Strengths & Weaknesses
7.16 Misonix
7.16.1 Misonix Details
7.16.2 Misonix Major Business
7.16.3 Misonix Interventional Oncology Ablation Device Product and Services
7.16.4 Misonix Interventional Oncology Ablation Device Revenue, Gross Margin and Market Share (2021-2026)
7.16.5 Misonix Recent Developments/Updates
7.16.6 Misonix Competitive Strengths & Weaknesses
8 INDUSTRY CHAIN ANALYSIS
8.1 Interventional Oncology Ablation Device Industry Chain
8.2 Interventional Oncology Ablation Device Upstream Analysis
8.3 Interventional Oncology Ablation Device Midstream Analysis
8.4 Interventional Oncology Ablation Device Downstream Analysis
9 RESEARCH FINDINGS AND CONCLUSION
10 APPENDIX
10.1 Methodology
10.2 Research Process and Data Source
10.3 Disclaimer
1.1 Interventional Oncology Ablation Device Introduction
1.2 World Interventional Oncology Ablation Device Market Size & Forecast (2021 & 2025 & 2032)
1.3 World Interventional Oncology Ablation Device Total Market by Region (by Headquarter Location)
1.3.1 World Interventional Oncology Ablation Device Market Size by Region (2021-2032), (by Headquarter Location)
1.3.2 United States Based Company Interventional Oncology Ablation Device Revenue (2021-2032)
1.3.3 China Based Company Interventional Oncology Ablation Device Revenue (2021-2032)
1.3.4 Europe Based Company Interventional Oncology Ablation Device Revenue (2021-2032)
1.3.5 Japan Based Company Interventional Oncology Ablation Device Revenue (2021-2032)
1.3.6 South Korea Based Company Interventional Oncology Ablation Device Revenue (2021-2032)
1.3.7 ASEAN Based Company Interventional Oncology Ablation Device Revenue (2021-2032)
1.3.8 India Based Company Interventional Oncology Ablation Device Revenue (2021-2032)
1.4 Market Drivers, Restraints and Trends
1.4.1 Interventional Oncology Ablation Device Market Drivers
1.4.2 Factors Affecting Demand
1.4.3 Major Market Trends
2 DEMAND SUMMARY
2.1 World Interventional Oncology Ablation Device Consumption Value (2021-2032)
2.2 World Interventional Oncology Ablation Device Consumption Value by Region
2.2.1 World Interventional Oncology Ablation Device Consumption Value by Region (2021-2026)
2.2.2 World Interventional Oncology Ablation Device Consumption Value Forecast by Region (2027-2032)
2.3 United States Interventional Oncology Ablation Device Consumption Value (2021-2032)
2.4 China Interventional Oncology Ablation Device Consumption Value (2021-2032)
2.5 Europe Interventional Oncology Ablation Device Consumption Value (2021-2032)
2.6 Japan Interventional Oncology Ablation Device Consumption Value (2021-2032)
2.7 South Korea Interventional Oncology Ablation Device Consumption Value (2021-2032)
2.8 ASEAN Interventional Oncology Ablation Device Consumption Value (2021-2032)
2.9 India Interventional Oncology Ablation Device Consumption Value (2021-2032)
3 WORLD INTERVENTIONAL ONCOLOGY ABLATION DEVICE COMPANIES COMPETITIVE ANALYSIS
3.1 World Interventional Oncology Ablation Device Revenue by Player (2021-2026)
3.2 Industry Rank and Concentration Rate (CR)
3.2.1 Global Interventional Oncology Ablation Device Industry Rank of Major Players
3.2.2 Global Concentration Ratios (CR4) for Interventional Oncology Ablation Device in 2025
3.2.3 Global Concentration Ratios (CR8) for Interventional Oncology Ablation Device in 2025
3.3 Interventional Oncology Ablation Device Company Evaluation Quadrant
3.4 Interventional Oncology Ablation Device Market: Overall Company Footprint Analysis
3.4.1 Interventional Oncology Ablation Device Market: Region Footprint
3.4.2 Interventional Oncology Ablation Device Market: Company Product Type Footprint
3.4.3 Interventional Oncology Ablation Device Market: Company Product Application Footprint
3.5 Competitive Environment
3.5.1 Historical Structure of the Industry
3.5.2 Barriers of Market Entry
3.5.3 Factors of Competition
3.6 Mergers & Acquisitions Activity
4 UNITED STATES VS CHINA VS REST OF WORLD (BY HEADQUARTER LOCATION)
4.1 United States VS China: Interventional Oncology Ablation Device Revenue Comparison (by Headquarter Location)
4.1.1 United States VS China: Interventional Oncology Ablation Device Revenue Comparison (2021 & 2025 & 2032) (by Headquarter Location)
4.1.2 United States VS China: Interventional Oncology Ablation Device Revenue Market Share Comparison (2021 & 2025 & 2032)
4.2 United States Based Companies VS China Based Companies: Interventional Oncology Ablation Device Consumption Value Comparison
4.2.1 United States VS China: Interventional Oncology Ablation Device Consumption Value Comparison (2021 & 2025 & 2032)
4.2.2 United States VS China: Interventional Oncology Ablation Device Consumption Value Market Share Comparison (2021 & 2025 & 2032)
4.3 United States Based Interventional Oncology Ablation Device Companies and Market Share, 2021-2026
4.3.1 United States Based Interventional Oncology Ablation Device Companies, Headquarters (States, Country)
4.3.2 United States Based Companies Interventional Oncology Ablation Device Revenue, (2021-2026)
4.4 China Based Companies Interventional Oncology Ablation Device Revenue and Market Share, 2021-2026
4.4.1 China Based Interventional Oncology Ablation Device Companies, Company Headquarters (Province, Country)
4.4.2 China Based Companies Interventional Oncology Ablation Device Revenue, (2021-2026)
4.5 Rest of World Based Interventional Oncology Ablation Device Companies and Market Share, 2021-2026
4.5.1 Rest of World Based Interventional Oncology Ablation Device Companies, Headquarters (Province, Country)
4.5.2 Rest of World Based Companies Interventional Oncology Ablation Device Revenue (2021-2026)
5 MARKET ANALYSIS BY ENERGY SOURCE
5.1 World Interventional Oncology Ablation Device Market Size Overview by Energy Source: 2021 VS 2025 VS 2032
5.2 Segment Introduction by Energy Source
5.2.1 Microwave Ablation
5.2.2 Radiofrequency Ablation
5.2.3 Cryoablation
5.2.4 High-Intensity Focused Ultrasound (HIFU)
5.2.5 Others
5.3 Market Segment by Energy Source
5.3.1 World Interventional Oncology Ablation Device Market Size by Energy Source (2021-2026)
5.3.2 World Interventional Oncology Ablation Device Market Size by Energy Source (2027-2032)
5.3.3 World Interventional Oncology Ablation Device Market Size Market Share by Energy Source (2027-2032)
6 MARKET ANALYSIS BY PROCEDURE TYPE
6.1 World Interventional Oncology Ablation Device Market Size Overview by Procedure Type: 2021 VS 2025 VS 2032
6.2 Segment Introduction by Procedure Type
6.2.1 Liver Cancer
6.2.2 Lung Cancer
6.2.3 Breast Cancer
6.2.4 Other
6.3 Market Segment by Procedure Type
6.3.1 World Interventional Oncology Ablation Device Market Size by Procedure Type (2021-2026)
6.3.2 World Interventional Oncology Ablation Device Market Size by Procedure Type (2027-2032)
6.3.3 World Interventional Oncology Ablation Device Market Size Market Share by Procedure Type (2021-2032)
7 COMPANY PROFILES
7.1 Chongqing Haifu Medical
7.1.1 Chongqing Haifu Medical Details
7.1.2 Chongqing Haifu Medical Major Business
7.1.3 Chongqing Haifu Medical Interventional Oncology Ablation Device Product and Services
7.1.4 Chongqing Haifu Medical Interventional Oncology Ablation Device Revenue, Gross Margin and Market Share (2021-2026)
7.1.5 Chongqing Haifu Medical Recent Developments/Updates
7.1.6 Chongqing Haifu Medical Competitive Strengths & Weaknesses
7.2 AngioDynamics
7.2.1 AngioDynamics Details
7.2.2 AngioDynamics Major Business
7.2.3 AngioDynamics Interventional Oncology Ablation Device Product and Services
7.2.4 AngioDynamics Interventional Oncology Ablation Device Revenue, Gross Margin and Market Share (2021-2026)
7.2.5 AngioDynamics Recent Developments/Updates
7.2.6 AngioDynamics Competitive Strengths & Weaknesses
7.3 Boston Scientific
7.3.1 Boston Scientific Details
7.3.2 Boston Scientific Major Business
7.3.3 Boston Scientific Interventional Oncology Ablation Device Product and Services
7.3.4 Boston Scientific Interventional Oncology Ablation Device Revenue, Gross Margin and Market Share (2021-2026)
7.3.5 Boston Scientific Recent Developments/Updates
7.3.6 Boston Scientific Competitive Strengths & Weaknesses
7.4 Medtronic
7.4.1 Medtronic Details
7.4.2 Medtronic Major Business
7.4.3 Medtronic Interventional Oncology Ablation Device Product and Services
7.4.4 Medtronic Interventional Oncology Ablation Device Revenue, Gross Margin and Market Share (2021-2026)
7.4.5 Medtronic Recent Developments/Updates
7.4.6 Medtronic Competitive Strengths & Weaknesses
7.5 Yigao Medical
7.5.1 Yigao Medical Details
7.5.2 Yigao Medical Major Business
7.5.3 Yigao Medical Interventional Oncology Ablation Device Product and Services
7.5.4 Yigao Medical Interventional Oncology Ablation Device Revenue, Gross Margin and Market Share (2021-2026)
7.5.5 Yigao Medical Recent Developments/Updates
7.5.6 Yigao Medical Competitive Strengths & Weaknesses
7.6 Haijieya
7.6.1 Haijieya Details
7.6.2 Haijieya Major Business
7.6.3 Haijieya Interventional Oncology Ablation Device Product and Services
7.6.4 Haijieya Interventional Oncology Ablation Device Revenue, Gross Margin and Market Share (2021-2026)
7.6.5 Haijieya Recent Developments/Updates
7.6.6 Haijieya Competitive Strengths & Weaknesses
7.7 Beijing Weierfu
7.7.1 Beijing Weierfu Details
7.7.2 Beijing Weierfu Major Business
7.7.3 Beijing Weierfu Interventional Oncology Ablation Device Product and Services
7.7.4 Beijing Weierfu Interventional Oncology Ablation Device Revenue, Gross Margin and Market Share (2021-2026)
7.7.5 Beijing Weierfu Recent Developments/Updates
7.7.6 Beijing Weierfu Competitive Strengths & Weaknesses
7.8 Micro Tech Medical
7.8.1 Micro Tech Medical Details
7.8.2 Micro Tech Medical Major Business
7.8.3 Micro Tech Medical Interventional Oncology Ablation Device Product and Services
7.8.4 Micro Tech Medical Interventional Oncology Ablation Device Revenue, Gross Margin and Market Share (2021-2026)
7.8.5 Micro Tech Medical Recent Developments/Updates
7.8.6 Micro Tech Medical Competitive Strengths & Weaknesses
7.9 Better Medical
7.9.1 Better Medical Details
7.9.2 Better Medical Major Business
7.9.3 Better Medical Interventional Oncology Ablation Device Product and Services
7.9.4 Better Medical Interventional Oncology Ablation Device Revenue, Gross Margin and Market Share (2021-2026)
7.9.5 Better Medical Recent Developments/Updates
7.9.6 Better Medical Competitive Strengths & Weaknesses
7.10 Vison Medical
7.10.1 Vison Medical Details
7.10.2 Vison Medical Major Business
7.10.3 Vison Medical Interventional Oncology Ablation Device Product and Services
7.10.4 Vison Medical Interventional Oncology Ablation Device Revenue, Gross Margin and Market Share (2021-2026)
7.10.5 Vison Medical Recent Developments/Updates
7.10.6 Vison Medical Competitive Strengths & Weaknesses
7.11 Shanghai Maide
7.11.1 Shanghai Maide Details
7.11.2 Shanghai Maide Major Business
7.11.3 Shanghai Maide Interventional Oncology Ablation Device Product and Services
7.11.4 Shanghai Maide Interventional Oncology Ablation Device Revenue, Gross Margin and Market Share (2021-2026)
7.11.5 Shanghai Maide Recent Developments/Updates
7.11.6 Shanghai Maide Competitive Strengths & Weaknesses
7.12 HealthTronics
7.12.1 HealthTronics Details
7.12.2 HealthTronics Major Business
7.12.3 HealthTronics Interventional Oncology Ablation Device Product and Services
7.12.4 HealthTronics Interventional Oncology Ablation Device Revenue, Gross Margin and Market Share (2021-2026)
7.12.5 HealthTronics Recent Developments/Updates
7.12.6 HealthTronics Competitive Strengths & Weaknesses
7.13 J &J
7.13.1 J &J Details
7.13.2 J &J Major Business
7.13.3 J &J Interventional Oncology Ablation Device Product and Services
7.13.4 J &J Interventional Oncology Ablation Device Revenue, Gross Margin and Market Share (2021-2026)
7.13.5 J &J Recent Developments/Updates
7.13.6 J &J Competitive Strengths & Weaknesses
7.14 EDAP TMS
7.14.1 EDAP TMS Details
7.14.2 EDAP TMS Major Business
7.14.3 EDAP TMS Interventional Oncology Ablation Device Product and Services
7.14.4 EDAP TMS Interventional Oncology Ablation Device Revenue, Gross Margin and Market Share (2021-2026)
7.14.5 EDAP TMS Recent Developments/Updates
7.14.6 EDAP TMS Competitive Strengths & Weaknesses
7.15 Sonacare Medical
7.15.1 Sonacare Medical Details
7.15.2 Sonacare Medical Major Business
7.15.3 Sonacare Medical Interventional Oncology Ablation Device Product and Services
7.15.4 Sonacare Medical Interventional Oncology Ablation Device Revenue, Gross Margin and Market Share (2021-2026)
7.15.5 Sonacare Medical Recent Developments/Updates
7.15.6 Sonacare Medical Competitive Strengths & Weaknesses
7.16 Misonix
7.16.1 Misonix Details
7.16.2 Misonix Major Business
7.16.3 Misonix Interventional Oncology Ablation Device Product and Services
7.16.4 Misonix Interventional Oncology Ablation Device Revenue, Gross Margin and Market Share (2021-2026)
7.16.5 Misonix Recent Developments/Updates
7.16.6 Misonix Competitive Strengths & Weaknesses
8 INDUSTRY CHAIN ANALYSIS
8.1 Interventional Oncology Ablation Device Industry Chain
8.2 Interventional Oncology Ablation Device Upstream Analysis
8.3 Interventional Oncology Ablation Device Midstream Analysis
8.4 Interventional Oncology Ablation Device Downstream Analysis
9 RESEARCH FINDINGS AND CONCLUSION
10 APPENDIX
10.1 Methodology
10.2 Research Process and Data Source
10.3 Disclaimer
LIST OF TABLES
Table 1. World Interventional Oncology Ablation Device Revenue by Region (2021, 2025 and 2032) & (USD Million), (by Headquarter Location)
Table 2. World Interventional Oncology Ablation Device Revenue by Region (2021-2026) & (USD Million), (by Headquarter Location)
Table 3. World Interventional Oncology Ablation Device Revenue by Region (2027-2032) & (USD Million), (by Headquarter Location)
Table 4. World Interventional Oncology Ablation Device Revenue Market Share by Region (2021-2026), (by Headquarter Location)
Table 5. World Interventional Oncology Ablation Device Revenue Market Share by Region (2027-2032), (by Headquarter Location)
Table 6. Major Market Trends
Table 7. World Interventional Oncology Ablation Device Consumption Value Growth Rate Forecast by Region (2021 & 2025 & 2032) & (USD Million)
Table 8. World Interventional Oncology Ablation Device Consumption Value by Region (2021-2026) & (USD Million)
Table 9. World Interventional Oncology Ablation Device Consumption Value Forecast by Region (2027-2032) & (USD Million)
Table 10. World Interventional Oncology Ablation Device Revenue by Player (2021-2026) & (USD Million)
Table 11. Revenue Market Share of Key Interventional Oncology Ablation Device Players in 2025
Table 12. World Interventional Oncology Ablation Device Industry Rank of Major Player, Based on Revenue in 2025
Table 13. Global Interventional Oncology Ablation Device Company Evaluation Quadrant
Table 14. Head Office of Key Interventional Oncology Ablation Device Players
Table 15. Interventional Oncology Ablation Device Market: Company Product Type Footprint
Table 16. Interventional Oncology Ablation Device Market: Company Product Application Footprint
Table 17. Interventional Oncology Ablation Device Mergers & Acquisitions Activity
Table 18. United States VS China Interventional Oncology Ablation Device Revenue Comparison, (2021 & 2025 & 2032) & (USD Million)
Table 19. United States VS China Interventional Oncology Ablation Device Consumption Value Comparison, (2021 & 2025 & 2032) & (USD Million)
Table 20. United States Based Interventional Oncology Ablation Device Companies, Headquarters (States, Country)
Table 21. United States Based Companies Interventional Oncology Ablation Device Revenue, (2021-2026) & (USD Million)
Table 22. United States Based Companies Interventional Oncology Ablation Device Revenue Market Share (2021-2026)
Table 23. China Based Interventional Oncology Ablation Device Companies, Headquarters (Province, Country)
Table 24. China Based Companies Interventional Oncology Ablation Device Revenue, (2021-2026) & (USD Million)
Table 25. China Based Companies Interventional Oncology Ablation Device Revenue Market Share (2021-2026)
Table 26. Rest of World Based Interventional Oncology Ablation Device Companies, Headquarters (Province, Country)
Table 27. Rest of World Based Companies Interventional Oncology Ablation Device Revenue (2021-2026) & (USD Million)
Table 28. Rest of World Based Companies Interventional Oncology Ablation Device Revenue Market Share (2021-2026)
Table 29. World Interventional Oncology Ablation Device Market Size by Energy Source, (USD Million), 2021 & 2025 & 2032
Table 30. World Interventional Oncology Ablation Device Market Size Value by Energy Source (2021-2026) & (USD Million)
Table 31. World Interventional Oncology Ablation Device Market Size by Energy Source (2027-2032) & (USD Million)
Table 32. World Interventional Oncology Ablation Device Market Size by Procedure Type, (USD Million), 2021 & 2025 & 2032
Table 33. World Interventional Oncology Ablation Device Market Size by Procedure Type (2021-2026) & (USD Million)
Table 34. World Interventional Oncology Ablation Device Market Size by Procedure Type (2027-2032) & (USD Million)
Table 35. Chongqing Haifu Medical Basic Information, Manufacturing Base and Competitors
Table 36. Chongqing Haifu Medical Major Business
Table 37. Chongqing Haifu Medical Interventional Oncology Ablation Device Product and Services
Table 38. Chongqing Haifu Medical Interventional Oncology Ablation Device Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 39. Chongqing Haifu Medical Recent Developments/Updates
Table 40. Chongqing Haifu Medical Competitive Strengths & Weaknesses
Table 41. AngioDynamics Basic Information, Manufacturing Base and Competitors
Table 42. AngioDynamics Major Business
Table 43. AngioDynamics Interventional Oncology Ablation Device Product and Services
Table 44. AngioDynamics Interventional Oncology Ablation Device Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 45. AngioDynamics Recent Developments/Updates
Table 46. AngioDynamics Competitive Strengths & Weaknesses
Table 47. Boston Scientific Basic Information, Manufacturing Base and Competitors
Table 48. Boston Scientific Major Business
Table 49. Boston Scientific Interventional Oncology Ablation Device Product and Services
Table 50. Boston Scientific Interventional Oncology Ablation Device Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 51. Boston Scientific Recent Developments/Updates
Table 52. Boston Scientific Competitive Strengths & Weaknesses
Table 53. Medtronic Basic Information, Manufacturing Base and Competitors
Table 54. Medtronic Major Business
Table 55. Medtronic Interventional Oncology Ablation Device Product and Services
Table 56. Medtronic Interventional Oncology Ablation Device Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 57. Medtronic Recent Developments/Updates
Table 58. Medtronic Competitive Strengths & Weaknesses
Table 59. Yigao Medical Basic Information, Manufacturing Base and Competitors
Table 60. Yigao Medical Major Business
Table 61. Yigao Medical Interventional Oncology Ablation Device Product and Services
Table 62. Yigao Medical Interventional Oncology Ablation Device Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 63. Yigao Medical Recent Developments/Updates
Table 64. Yigao Medical Competitive Strengths & Weaknesses
Table 65. Haijieya Basic Information, Manufacturing Base and Competitors
Table 66. Haijieya Major Business
Table 67. Haijieya Interventional Oncology Ablation Device Product and Services
Table 68. Haijieya Interventional Oncology Ablation Device Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 69. Haijieya Recent Developments/Updates
Table 70. Haijieya Competitive Strengths & Weaknesses
Table 71. Beijing Weierfu Basic Information, Manufacturing Base and Competitors
Table 72. Beijing Weierfu Major Business
Table 73. Beijing Weierfu Interventional Oncology Ablation Device Product and Services
Table 74. Beijing Weierfu Interventional Oncology Ablation Device Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 75. Beijing Weierfu Recent Developments/Updates
Table 76. Beijing Weierfu Competitive Strengths & Weaknesses
Table 77. Micro Tech Medical Basic Information, Manufacturing Base and Competitors
Table 78. Micro Tech Medical Major Business
Table 79. Micro Tech Medical Interventional Oncology Ablation Device Product and Services
Table 80. Micro Tech Medical Interventional Oncology Ablation Device Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 81. Micro Tech Medical Recent Developments/Updates
Table 82. Micro Tech Medical Competitive Strengths & Weaknesses
Table 83. Better Medical Basic Information, Manufacturing Base and Competitors
Table 84. Better Medical Major Business
Table 85. Better Medical Interventional Oncology Ablation Device Product and Services
Table 86. Better Medical Interventional Oncology Ablation Device Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 87. Better Medical Recent Developments/Updates
Table 88. Better Medical Competitive Strengths & Weaknesses
Table 89. Vison Medical Basic Information, Manufacturing Base and Competitors
Table 90. Vison Medical Major Business
Table 91. Vison Medical Interventional Oncology Ablation Device Product and Services
Table 92. Vison Medical Interventional Oncology Ablation Device Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 93. Vison Medical Recent Developments/Updates
Table 94. Vison Medical Competitive Strengths & Weaknesses
Table 95. Shanghai Maide Basic Information, Manufacturing Base and Competitors
Table 96. Shanghai Maide Major Business
Table 97. Shanghai Maide Interventional Oncology Ablation Device Product and Services
Table 98. Shanghai Maide Interventional Oncology Ablation Device Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 99. Shanghai Maide Recent Developments/Updates
Table 100. Shanghai Maide Competitive Strengths & Weaknesses
Table 101. HealthTronics Basic Information, Manufacturing Base and Competitors
Table 102. HealthTronics Major Business
Table 103. HealthTronics Interventional Oncology Ablation Device Product and Services
Table 104. HealthTronics Interventional Oncology Ablation Device Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 105. HealthTronics Recent Developments/Updates
Table 106. HealthTronics Competitive Strengths & Weaknesses
Table 107. J &J Basic Information, Manufacturing Base and Competitors
Table 108. J &J Major Business
Table 109. J &J Interventional Oncology Ablation Device Product and Services
Table 110. J &J Interventional Oncology Ablation Device Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 111. J &J Recent Developments/Updates
Table 112. J &J Competitive Strengths & Weaknesses
Table 113. EDAP TMS Basic Information, Manufacturing Base and Competitors
Table 114. EDAP TMS Major Business
Table 115. EDAP TMS Interventional Oncology Ablation Device Product and Services
Table 116. EDAP TMS Interventional Oncology Ablation Device Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 117. EDAP TMS Recent Developments/Updates
Table 118. EDAP TMS Competitive Strengths & Weaknesses
Table 119. Sonacare Medical Basic Information, Manufacturing Base and Competitors
Table 120. Sonacare Medical Major Business
Table 121. Sonacare Medical Interventional Oncology Ablation Device Product and Services
Table 122. Sonacare Medical Interventional Oncology Ablation Device Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 123. Sonacare Medical Recent Developments/Updates
Table 124. Sonacare Medical Competitive Strengths & Weaknesses
Table 125. Misonix Basic Information, Manufacturing Base and Competitors
Table 126. Misonix Major Business
Table 127. Misonix Interventional Oncology Ablation Device Product and Services
Table 128. Misonix Interventional Oncology Ablation Device Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 129. Misonix Recent Developments/Updates
Table 130. Misonix Competitive Strengths & Weaknesses
Table 131. Global Key Players of Interventional Oncology Ablation Device Upstream (Raw Materials)
Table 132. Global Interventional Oncology Ablation Device Typical Customers
Table 1. World Interventional Oncology Ablation Device Revenue by Region (2021, 2025 and 2032) & (USD Million), (by Headquarter Location)
Table 2. World Interventional Oncology Ablation Device Revenue by Region (2021-2026) & (USD Million), (by Headquarter Location)
Table 3. World Interventional Oncology Ablation Device Revenue by Region (2027-2032) & (USD Million), (by Headquarter Location)
Table 4. World Interventional Oncology Ablation Device Revenue Market Share by Region (2021-2026), (by Headquarter Location)
Table 5. World Interventional Oncology Ablation Device Revenue Market Share by Region (2027-2032), (by Headquarter Location)
Table 6. Major Market Trends
Table 7. World Interventional Oncology Ablation Device Consumption Value Growth Rate Forecast by Region (2021 & 2025 & 2032) & (USD Million)
Table 8. World Interventional Oncology Ablation Device Consumption Value by Region (2021-2026) & (USD Million)
Table 9. World Interventional Oncology Ablation Device Consumption Value Forecast by Region (2027-2032) & (USD Million)
Table 10. World Interventional Oncology Ablation Device Revenue by Player (2021-2026) & (USD Million)
Table 11. Revenue Market Share of Key Interventional Oncology Ablation Device Players in 2025
Table 12. World Interventional Oncology Ablation Device Industry Rank of Major Player, Based on Revenue in 2025
Table 13. Global Interventional Oncology Ablation Device Company Evaluation Quadrant
Table 14. Head Office of Key Interventional Oncology Ablation Device Players
Table 15. Interventional Oncology Ablation Device Market: Company Product Type Footprint
Table 16. Interventional Oncology Ablation Device Market: Company Product Application Footprint
Table 17. Interventional Oncology Ablation Device Mergers & Acquisitions Activity
Table 18. United States VS China Interventional Oncology Ablation Device Revenue Comparison, (2021 & 2025 & 2032) & (USD Million)
Table 19. United States VS China Interventional Oncology Ablation Device Consumption Value Comparison, (2021 & 2025 & 2032) & (USD Million)
Table 20. United States Based Interventional Oncology Ablation Device Companies, Headquarters (States, Country)
Table 21. United States Based Companies Interventional Oncology Ablation Device Revenue, (2021-2026) & (USD Million)
Table 22. United States Based Companies Interventional Oncology Ablation Device Revenue Market Share (2021-2026)
Table 23. China Based Interventional Oncology Ablation Device Companies, Headquarters (Province, Country)
Table 24. China Based Companies Interventional Oncology Ablation Device Revenue, (2021-2026) & (USD Million)
Table 25. China Based Companies Interventional Oncology Ablation Device Revenue Market Share (2021-2026)
Table 26. Rest of World Based Interventional Oncology Ablation Device Companies, Headquarters (Province, Country)
Table 27. Rest of World Based Companies Interventional Oncology Ablation Device Revenue (2021-2026) & (USD Million)
Table 28. Rest of World Based Companies Interventional Oncology Ablation Device Revenue Market Share (2021-2026)
Table 29. World Interventional Oncology Ablation Device Market Size by Energy Source, (USD Million), 2021 & 2025 & 2032
Table 30. World Interventional Oncology Ablation Device Market Size Value by Energy Source (2021-2026) & (USD Million)
Table 31. World Interventional Oncology Ablation Device Market Size by Energy Source (2027-2032) & (USD Million)
Table 32. World Interventional Oncology Ablation Device Market Size by Procedure Type, (USD Million), 2021 & 2025 & 2032
Table 33. World Interventional Oncology Ablation Device Market Size by Procedure Type (2021-2026) & (USD Million)
Table 34. World Interventional Oncology Ablation Device Market Size by Procedure Type (2027-2032) & (USD Million)
Table 35. Chongqing Haifu Medical Basic Information, Manufacturing Base and Competitors
Table 36. Chongqing Haifu Medical Major Business
Table 37. Chongqing Haifu Medical Interventional Oncology Ablation Device Product and Services
Table 38. Chongqing Haifu Medical Interventional Oncology Ablation Device Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 39. Chongqing Haifu Medical Recent Developments/Updates
Table 40. Chongqing Haifu Medical Competitive Strengths & Weaknesses
Table 41. AngioDynamics Basic Information, Manufacturing Base and Competitors
Table 42. AngioDynamics Major Business
Table 43. AngioDynamics Interventional Oncology Ablation Device Product and Services
Table 44. AngioDynamics Interventional Oncology Ablation Device Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 45. AngioDynamics Recent Developments/Updates
Table 46. AngioDynamics Competitive Strengths & Weaknesses
Table 47. Boston Scientific Basic Information, Manufacturing Base and Competitors
Table 48. Boston Scientific Major Business
Table 49. Boston Scientific Interventional Oncology Ablation Device Product and Services
Table 50. Boston Scientific Interventional Oncology Ablation Device Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 51. Boston Scientific Recent Developments/Updates
Table 52. Boston Scientific Competitive Strengths & Weaknesses
Table 53. Medtronic Basic Information, Manufacturing Base and Competitors
Table 54. Medtronic Major Business
Table 55. Medtronic Interventional Oncology Ablation Device Product and Services
Table 56. Medtronic Interventional Oncology Ablation Device Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 57. Medtronic Recent Developments/Updates
Table 58. Medtronic Competitive Strengths & Weaknesses
Table 59. Yigao Medical Basic Information, Manufacturing Base and Competitors
Table 60. Yigao Medical Major Business
Table 61. Yigao Medical Interventional Oncology Ablation Device Product and Services
Table 62. Yigao Medical Interventional Oncology Ablation Device Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 63. Yigao Medical Recent Developments/Updates
Table 64. Yigao Medical Competitive Strengths & Weaknesses
Table 65. Haijieya Basic Information, Manufacturing Base and Competitors
Table 66. Haijieya Major Business
Table 67. Haijieya Interventional Oncology Ablation Device Product and Services
Table 68. Haijieya Interventional Oncology Ablation Device Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 69. Haijieya Recent Developments/Updates
Table 70. Haijieya Competitive Strengths & Weaknesses
Table 71. Beijing Weierfu Basic Information, Manufacturing Base and Competitors
Table 72. Beijing Weierfu Major Business
Table 73. Beijing Weierfu Interventional Oncology Ablation Device Product and Services
Table 74. Beijing Weierfu Interventional Oncology Ablation Device Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 75. Beijing Weierfu Recent Developments/Updates
Table 76. Beijing Weierfu Competitive Strengths & Weaknesses
Table 77. Micro Tech Medical Basic Information, Manufacturing Base and Competitors
Table 78. Micro Tech Medical Major Business
Table 79. Micro Tech Medical Interventional Oncology Ablation Device Product and Services
Table 80. Micro Tech Medical Interventional Oncology Ablation Device Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 81. Micro Tech Medical Recent Developments/Updates
Table 82. Micro Tech Medical Competitive Strengths & Weaknesses
Table 83. Better Medical Basic Information, Manufacturing Base and Competitors
Table 84. Better Medical Major Business
Table 85. Better Medical Interventional Oncology Ablation Device Product and Services
Table 86. Better Medical Interventional Oncology Ablation Device Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 87. Better Medical Recent Developments/Updates
Table 88. Better Medical Competitive Strengths & Weaknesses
Table 89. Vison Medical Basic Information, Manufacturing Base and Competitors
Table 90. Vison Medical Major Business
Table 91. Vison Medical Interventional Oncology Ablation Device Product and Services
Table 92. Vison Medical Interventional Oncology Ablation Device Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 93. Vison Medical Recent Developments/Updates
Table 94. Vison Medical Competitive Strengths & Weaknesses
Table 95. Shanghai Maide Basic Information, Manufacturing Base and Competitors
Table 96. Shanghai Maide Major Business
Table 97. Shanghai Maide Interventional Oncology Ablation Device Product and Services
Table 98. Shanghai Maide Interventional Oncology Ablation Device Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 99. Shanghai Maide Recent Developments/Updates
Table 100. Shanghai Maide Competitive Strengths & Weaknesses
Table 101. HealthTronics Basic Information, Manufacturing Base and Competitors
Table 102. HealthTronics Major Business
Table 103. HealthTronics Interventional Oncology Ablation Device Product and Services
Table 104. HealthTronics Interventional Oncology Ablation Device Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 105. HealthTronics Recent Developments/Updates
Table 106. HealthTronics Competitive Strengths & Weaknesses
Table 107. J &J Basic Information, Manufacturing Base and Competitors
Table 108. J &J Major Business
Table 109. J &J Interventional Oncology Ablation Device Product and Services
Table 110. J &J Interventional Oncology Ablation Device Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 111. J &J Recent Developments/Updates
Table 112. J &J Competitive Strengths & Weaknesses
Table 113. EDAP TMS Basic Information, Manufacturing Base and Competitors
Table 114. EDAP TMS Major Business
Table 115. EDAP TMS Interventional Oncology Ablation Device Product and Services
Table 116. EDAP TMS Interventional Oncology Ablation Device Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 117. EDAP TMS Recent Developments/Updates
Table 118. EDAP TMS Competitive Strengths & Weaknesses
Table 119. Sonacare Medical Basic Information, Manufacturing Base and Competitors
Table 120. Sonacare Medical Major Business
Table 121. Sonacare Medical Interventional Oncology Ablation Device Product and Services
Table 122. Sonacare Medical Interventional Oncology Ablation Device Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 123. Sonacare Medical Recent Developments/Updates
Table 124. Sonacare Medical Competitive Strengths & Weaknesses
Table 125. Misonix Basic Information, Manufacturing Base and Competitors
Table 126. Misonix Major Business
Table 127. Misonix Interventional Oncology Ablation Device Product and Services
Table 128. Misonix Interventional Oncology Ablation Device Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 129. Misonix Recent Developments/Updates
Table 130. Misonix Competitive Strengths & Weaknesses
Table 131. Global Key Players of Interventional Oncology Ablation Device Upstream (Raw Materials)
Table 132. Global Interventional Oncology Ablation Device Typical Customers
LIST OF FIGURES
Figure 1. Interventional Oncology Ablation Device Picture
Figure 2. World Interventional Oncology Ablation Device Total Revenue: 2021 & 2025 & 2032, (USD Million)
Figure 3. World Interventional Oncology Ablation Device Total Revenue (2021-2032) & (USD Million)
Figure 4. World Interventional Oncology Ablation Device Revenue by Region (2021, 2025 and 2032) & (USD Million), (by Headquarter Location)
Figure 5. World Interventional Oncology Ablation Device Revenue Market Share by Region (2021-2032), (by Headquarter Location)
Figure 6. United States Based Company Interventional Oncology Ablation Device Revenue (2021-2032) & (USD Million)
Figure 7. China Based Company Interventional Oncology Ablation Device Revenue (2021-2032) & (USD Million)
Figure 8. Europe Based Company Interventional Oncology Ablation Device Revenue (2021-2032) & (USD Million)
Figure 9. Japan Based Company Interventional Oncology Ablation Device Revenue (2021-2032) & (USD Million)
Figure 10. South Korea Based Company Interventional Oncology Ablation Device Revenue (2021-2032) & (USD Million)
Figure 11. ASEAN Based Company Interventional Oncology Ablation Device Revenue (2021-2032) & (USD Million)
Figure 12. India Based Company Interventional Oncology Ablation Device Revenue (2021-2032) & (USD Million)
Figure 13. Interventional Oncology Ablation Device Market Drivers
Figure 14. Factors Affecting Demand
Figure 15. World Interventional Oncology Ablation Device Consumption Value (2021-2032) & (USD Million)
Figure 16. World Interventional Oncology Ablation Device Consumption Value Market Share by Region (2021-2032)
Figure 17. United States Interventional Oncology Ablation Device Consumption Value (2021-2032) & (USD Million)
Figure 18. China Interventional Oncology Ablation Device Consumption Value (2021-2032) & (USD Million)
Figure 19. Europe Interventional Oncology Ablation Device Consumption Value (2021-2032) & (USD Million)
Figure 20. Japan Interventional Oncology Ablation Device Consumption Value (2021-2032) & (USD Million)
Figure 21. South Korea Interventional Oncology Ablation Device Consumption Value (2021-2032) & (USD Million)
Figure 22. ASEAN Interventional Oncology Ablation Device Consumption Value (2021-2032) & (USD Million)
Figure 23. India Interventional Oncology Ablation Device Consumption Value (2021-2032) & (USD Million)
Figure 24. Producer Shipments of Interventional Oncology Ablation Device by Player Revenue ($MM) and Market Share (%): 2025
Figure 25. Global Four-firm Concentration Ratios (CR4) for Interventional Oncology Ablation Device Markets in 2025
Figure 26. Global Four-firm Concentration Ratios (CR8) for Interventional Oncology Ablation Device Markets in 2025
Figure 27. United States VS China: Interventional Oncology Ablation Device Revenue Market Share Comparison (2021 & 2025 & 2032)
Figure 28. United States VS China: Interventional Oncology Ablation Device Consumption Value Market Share Comparison (2021 & 2025 & 2032)
Figure 29. World Interventional Oncology Ablation Device Market Size by Energy Source, (USD Million), 2021 & 2025 & 2032
Figure 30. World Interventional Oncology Ablation Device Market Size Market Share by Energy Source in 2025
Figure 31. Microwave Ablation
Figure 32. Radiofrequency Ablation
Figure 33. Cryoablation
Figure 34. High-Intensity Focused Ultrasound (HIFU)
Figure 35. Others
Figure 36. World Interventional Oncology Ablation Device Market Size Market Share by Energy Source (2021-2032)
Figure 37. Thermal
Figure 38. Cryogenic
Figure 39. Percutaneous
Figure 40. Laparoscopic
Figure 41. Open
Figure 42. World Interventional Oncology Ablation Device Market Size by Procedure Type, (USD Million), 2021 & 2025 & 2032
Figure 43. World Interventional Oncology Ablation Device Market Size Market Share by Procedure Type in 2025
Figure 44. Liver Cancer
Figure 45. Lung Cancer
Figure 46. Breast Cancer
Figure 47. Other
Figure 48. World Interventional Oncology Ablation Device Market Size Market Share by Procedure Type (2021-2032)
Figure 49. Interventional Oncology Ablation Device Industrial Chain
Figure 50. Methodology
Figure 51. Research Process and Data Source
Figure 1. Interventional Oncology Ablation Device Picture
Figure 2. World Interventional Oncology Ablation Device Total Revenue: 2021 & 2025 & 2032, (USD Million)
Figure 3. World Interventional Oncology Ablation Device Total Revenue (2021-2032) & (USD Million)
Figure 4. World Interventional Oncology Ablation Device Revenue by Region (2021, 2025 and 2032) & (USD Million), (by Headquarter Location)
Figure 5. World Interventional Oncology Ablation Device Revenue Market Share by Region (2021-2032), (by Headquarter Location)
Figure 6. United States Based Company Interventional Oncology Ablation Device Revenue (2021-2032) & (USD Million)
Figure 7. China Based Company Interventional Oncology Ablation Device Revenue (2021-2032) & (USD Million)
Figure 8. Europe Based Company Interventional Oncology Ablation Device Revenue (2021-2032) & (USD Million)
Figure 9. Japan Based Company Interventional Oncology Ablation Device Revenue (2021-2032) & (USD Million)
Figure 10. South Korea Based Company Interventional Oncology Ablation Device Revenue (2021-2032) & (USD Million)
Figure 11. ASEAN Based Company Interventional Oncology Ablation Device Revenue (2021-2032) & (USD Million)
Figure 12. India Based Company Interventional Oncology Ablation Device Revenue (2021-2032) & (USD Million)
Figure 13. Interventional Oncology Ablation Device Market Drivers
Figure 14. Factors Affecting Demand
Figure 15. World Interventional Oncology Ablation Device Consumption Value (2021-2032) & (USD Million)
Figure 16. World Interventional Oncology Ablation Device Consumption Value Market Share by Region (2021-2032)
Figure 17. United States Interventional Oncology Ablation Device Consumption Value (2021-2032) & (USD Million)
Figure 18. China Interventional Oncology Ablation Device Consumption Value (2021-2032) & (USD Million)
Figure 19. Europe Interventional Oncology Ablation Device Consumption Value (2021-2032) & (USD Million)
Figure 20. Japan Interventional Oncology Ablation Device Consumption Value (2021-2032) & (USD Million)
Figure 21. South Korea Interventional Oncology Ablation Device Consumption Value (2021-2032) & (USD Million)
Figure 22. ASEAN Interventional Oncology Ablation Device Consumption Value (2021-2032) & (USD Million)
Figure 23. India Interventional Oncology Ablation Device Consumption Value (2021-2032) & (USD Million)
Figure 24. Producer Shipments of Interventional Oncology Ablation Device by Player Revenue ($MM) and Market Share (%): 2025
Figure 25. Global Four-firm Concentration Ratios (CR4) for Interventional Oncology Ablation Device Markets in 2025
Figure 26. Global Four-firm Concentration Ratios (CR8) for Interventional Oncology Ablation Device Markets in 2025
Figure 27. United States VS China: Interventional Oncology Ablation Device Revenue Market Share Comparison (2021 & 2025 & 2032)
Figure 28. United States VS China: Interventional Oncology Ablation Device Consumption Value Market Share Comparison (2021 & 2025 & 2032)
Figure 29. World Interventional Oncology Ablation Device Market Size by Energy Source, (USD Million), 2021 & 2025 & 2032
Figure 30. World Interventional Oncology Ablation Device Market Size Market Share by Energy Source in 2025
Figure 31. Microwave Ablation
Figure 32. Radiofrequency Ablation
Figure 33. Cryoablation
Figure 34. High-Intensity Focused Ultrasound (HIFU)
Figure 35. Others
Figure 36. World Interventional Oncology Ablation Device Market Size Market Share by Energy Source (2021-2032)
Figure 37. Thermal
Figure 38. Cryogenic
Figure 39. Percutaneous
Figure 40. Laparoscopic
Figure 41. Open
Figure 42. World Interventional Oncology Ablation Device Market Size by Procedure Type, (USD Million), 2021 & 2025 & 2032
Figure 43. World Interventional Oncology Ablation Device Market Size Market Share by Procedure Type in 2025
Figure 44. Liver Cancer
Figure 45. Lung Cancer
Figure 46. Breast Cancer
Figure 47. Other
Figure 48. World Interventional Oncology Ablation Device Market Size Market Share by Procedure Type (2021-2032)
Figure 49. Interventional Oncology Ablation Device Industrial Chain
Figure 50. Methodology
Figure 51. Research Process and Data Source
